Jacquelyn Sandell
General Counsel bei JOUNCE THERAPEUTICS, INC.
Vermögen: 856 520 $ am 31.03.2024
Profil
Jacquelyn Fahey Sandell is currently the Secretary & Chief Legal Officer at Jounce Therapeutics, Inc. and the Chief Legal Officer at Voyager Therapeutics, Inc. She previously worked as an Associate General Counsel at Millennium Pharmaceuticals, Inc. from 2011 to 2015, as a Vice President & General Counsel at Vericel Corp., and as a Senior Corporate Counsel at Genzyme Corp.
from 2005 to 2011.
She received her undergraduate degree from Duke University and her graduate degree from Boston University School of Law.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 09.02.2024 | 92 000 ( 0,17% ) | 856 520 $ | 31.03.2024 |
Aktive Positionen von Jacquelyn Sandell
| Unternehmen | Position | Beginn |
|---|---|---|
| JOUNCE THERAPEUTICS, INC. | General Counsel | 17.09.2019 |
| VOYAGER THERAPEUTICS, INC. | General Counsel | 10.07.2023 |
Ehemalige bekannte Positionen von Jacquelyn Sandell
| Unternehmen | Position | Ende |
|---|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.01.2015 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | General Counsel | 01.01.2011 |
| VERICEL CORPORATION | General Counsel | - |
Ausbildung von Jacquelyn Sandell
| Duke University | Undergraduate Degree |
| Boston University School of Law | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| VERICEL CORPORATION | Health Technology |
| VOYAGER THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which engages in developing treatments for cancer. It also provides novel cancer immunotherapies to attack tumors. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber, and Padmanee Sharma in 2013 and is headquartered in Cambridge, MA. | Commercial Services |
